Baixinghua AI is an AI healthcare SaaS company founded in 2020 with a focus on revolutionizing clinical data and medical research through cutting-edge artificial intelligence technologies. The company's slogan, "Innovation through AI-driven insights for advanced medical research and clinical data integration," encapsulates its mission to enable free information flow in the medical field. The platform leverages machine learning, deep learning, and multimodal knowledge graphs to deliver comprehensive and accurate information for medical science and technology. This allows pharma companies, physicians, and researchers to conduct in-depth research on fundamental medical principles and drug mechanisms with AI analysis support. The last investment round took place on 29 November 2022, with an Angel Round investment from XTY Capital. This investment is expected to further propel Baixinghua AI's advancements in the healthcare industry and drive the integration of AI with clinical data, positioning the company as a key player in advancing medical research and technology.
No recent news or press coverage available for Baixinghua AI.